The Function and Mechanism of Circrnas in 5-Fluorouracil Resistance in Tumors: Biological Mechanisms and Future Potential Publisher Pubmed



Mafi A^{1, 2} ; Hedayati N³ ; Milasi YE² ; Kahkesh S⁴ ; Daviran M² ; Farahani N⁵ ; Hashemi M⁶ ; Nabavi N⁷ ; Alimohammadi M⁸ ; Rahimzadeh P⁹ ; Taheriazam A^{6, 10}
Source: Pathology Research and Practice Published:2024

Abstract

5-Fluorouracil (5-FU) is a well-known chemotherapy drug extensively used in the treatment of breast cancer. It works by inhibiting cancer cell proliferation and inducing cell death through direct incorporation into DNA and RNA via thymidylate synthase (TS). Circular RNAs (circRNAs), a novel family of endogenous non-coding RNAs (ncRNAs) with limited protein-coding potential, contribute to 5-FU resistance. Their identification and targeting are crucial for enhancing chemosensitivity. CircRNAs can regulate tumor formation and invasion by adhering to microRNAs (miRNAs) and interacting with RNA-binding proteins, regulating transcription and translation. MiRNAs can influence enzymes responsible for 5-FU metabolism in cancer cells, affecting their sensitivity or resistance to the drug. In the context of 5-FU resistance, circRNAs can target miRNAs and regulate biological processes such as cell proliferation, cell death, glucose metabolism, hypoxia, epithelial-to-mesenchymal transition (EMT), and drug efflux. This review focuses on the function of circRNAs in 5-FU resistance, discussing the underlying molecular pathways and biological mechanisms. It also presents recent circRNA/miRNA-targeted cancer therapeutic strategies for future clinical application. © 2024 Elsevier GmbH